Richard A. Ward

11.0k total citations · 1 hit paper
150 papers, 5.5k citations indexed

About

Richard A. Ward is a scholar working on Molecular Biology, Organic Chemistry and Nephrology. According to data from OpenAlex, Richard A. Ward has authored 150 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 31 papers in Organic Chemistry and 24 papers in Nephrology. Recurrent topics in Richard A. Ward's work include Dialysis and Renal Disease Management (19 papers), Lung Cancer Treatments and Mutations (14 papers) and Synthetic Organic Chemistry Methods (13 papers). Richard A. Ward is often cited by papers focused on Dialysis and Renal Disease Management (19 papers), Lung Cancer Treatments and Mutations (14 papers) and Synthetic Organic Chemistry Methods (13 papers). Richard A. Ward collaborates with scholars based in United States, United Kingdom and Australia. Richard A. Ward's co-authors include Kenneth R. McLeish, Richard Lonsdale, Ian Paterson, Julian D. Smith, Rosemary Ouseph, George Lominadze, Donald D. Clayton, Nicolas Floc’h, Kap‐Sun Yeung and Darren McKerrecher and has published in prestigious journals such as Nature, Chemical Reviews and The Lancet.

In The Last Decade

Richard A. Ward

145 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Challenges and Opportunities in Cancer Drug Resistance

2020 330 citations Richard A. Ward, Nicolas Floc’h et al. profile →

Peers

Countries citing papers authored by Richard A. Ward

Since Specialization

Citations

This map shows the geographic impact of Richard A. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard A. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard A. Ward more than expected).

Fields of papers citing papers by Richard A. Ward

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard A. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard A. Ward. The network helps show where Richard A. Ward may publish in the future.

Co-authorship network of co-authors of Richard A. Ward

This figure shows the co-authorship network connecting the top 25 collaborators of Richard A. Ward. A scholar is included among the top collaborators of Richard A. Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard A. Ward. Richard A. Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predicting protein–ligand binding affinity and correcting crystal structures with quantum mechanical calculations: lactate dehydrogenase A 2019 ·Chemical Science ·(unknown), (unknown), Richard A. Ward, Stephen A. St-Gallay, Judith C. Madden, Andrew G. Leach	11
2	Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions 2018 ·Molecular Cancer Therapeutics ·Nicolas Floc’h, Matthew J. Martin, Jonathan W. Riess, Jonathan P. Orme, Anna D. Staniszewska, Ludovic Ménard, Maria Emanuela Cuomo, Daniel O’Neill, Richard A. Ward, M. Raymond V. Finlay, Darren McKerrecher, Mingshan Cheng, (unknown), Rebekah A. Burich, James Keck, David R. Gandara, Philip C. Mack, Darren A.E. Cross	85
3	Functional Changes in Immunocompetent Cells Induced by Direct Cell/Membrane Interactions in Dialysis 2015 ·Contributions to nephrology ·(unknown), Richard A. Ward, (unknown), John Moran, Hans J. Gurland	0
4	Identification of DYRK1B as a substrate of ERK1/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome 2015 ·Cellular and Molecular Life Sciences ·(unknown), Tom Dunkley, Mark Cockerill, Rachel Rowlinson, (unknown), (unknown), Kathryn Balmanno, Louise Goodwin, Richard A. Ward, Pamela A. Lochhead, Sylvie M. Guichard, Kevin Hudson, Simon J. Cook	27
5	Rethinking the Bloody Code in Eighteenth-Century Britain: Capital Punishment at the Centre and on the Periphery 2015 ·Past & Present ·Peter King, Richard A. Ward	17
6	ALTERED BRAIN IRON HOMEOSTASIS IN PARKINSON'S DISEASE AND THE POTENTIAL FOR IRON CHELATION THERAPY 2013 ·UCL Discovery (University College London) ·David T. Dexter, Richard A. Ward, Robert R. Crichton, (unknown), (unknown)	2
7	Counterregulation of clathrin-mediated endocytosis by the actin and microtubular cytoskeleton in human neutrophils 2009 ·American Journal of Physiology-Cell Physiology ·Silvia M. Uriarte, Neelakshi R. Jog, Gregory C. Luerman, Samrath J. Bhimani, Richard A. Ward, Kenneth R. McLeish	28
8	Comparison of Proteins Expressed on Secretory Vesicle Membranes and Plasma Membranes of Human Neutrophils 2008 ·The Journal of Immunology ·Silvia M. Uriarte, David W. Powell, Gregory C. Luerman, Michael L. Merchant, Timothy D. Cummins, Neelakshi R. Jog, Richard A. Ward, Kenneth R. McLeish	83
9	Differences in solute removal by two high-flux membranes of nominally similar synthetic polymers 2007 ·Nephrology Dialysis Transplantation ·Rosemary Ouseph, Colin A. Hutchison, Richard A. Ward	48
10	Methylglyoxal: a stimulus to neutrophil oxygen radical production in chronic renal failure? 2004 ·Nephrology Dialysis Transplantation ·Richard A. Ward, Kenneth R. McLeish	39
11	Oxidant Stress in Hemodialysis Patients: What Are the Determining Factors? 2003 ·Artificial Organs ·Richard A. Ward, Kenneth R. McLeish	68
12	Priming of the Neutrophil Respiratory Burst Involves p38 Mitogen-activated Protein Kinase-dependent Exocytosis of Flavocytochrome b 558-containing Granules 2000 ·Journal of Biological Chemistry ·Richard A. Ward, Michio Nakamura, Kenneth R. McLeish	134
13	Soluble TNFα Receptors Are Increased in Chronic Renal Insufficiency and Hemodialysis and Inhibit Neutrophil Priming by TNFα 1996 ·Artificial Organs ·Richard A. Ward, Kenneth R. McLeish	12
14	Effect of Extracorporeal Membrane Oxygenation on Leukocyte Function in Neonates 1991 ·Artificial Organs ·James R. Hocker, Samuel R. Wellhausen, Richard A. Ward, Pippa Simpson, Larry N. Cook	39
15	Differential Activation of Monocytes in Haemodialysis Patients Exposed to Different Types of Membranes 1990 ·Scandinavian Journal of Immunology ·M Blumenstein, H.W.L. Ziegler-Heitbrock, (unknown), B. Schmidt, Richard A. Ward, H. J. Gurland	13
16	The Impact of Erythropoietin on Hemodialyzer Design and Performance 1989 ·Artificial Organs ·B. Schmidt, Richard A. Ward	7
17	Lu-176 - Cosmic clock or stellar thermometer 1981 ·The Astrophysical Journal Supplement Series ·H. Beer, F. Kaeppeler, K. Wisshak, Richard A. Ward	41
18	Importance of long-lived isomeric states in s-process branching 1977 ·The Astrophysical Journal ·Richard A. Ward	11
19	Branching in the s-Process. 1974 ·Bulletin of the American Astronomical Society ·Richard A. Ward, Donald D. Clayton, Michael Newman	1
20	MYOCARDIAL TOXOPLASMOSIS 1964 ·The Lancet ·Richard A. Ward, (unknown), (unknown), (unknown)	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact